Concepedia

Hendrik Andres

HA

18

Publications

553

Citations

13

H-Index

1978

Active since

Affiliations

Novartis (Switzerland)(Current)

Lawrence Berkeley National Laboratory

Novartis Institutes for BioMedical Research

University of Geneva

ETH Zurich

Hendrik Andres is an author at Novartis (Switzerland) specializing in chemistry, biochemistry, and engineering.

Top concepts

Publications per year

1978–2012

18

Publications

18

[3H]-M-MPEP, a Potent, Subtype-Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5

F. Gasparini, Hendrik Andres, Peter J. Flor et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 79 citations · Full text

, , +9

Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.

Ulrich Quast, K.M. Bray, Hendrik Andres et al. · Molecular Pharmacology · 1993 · 76 citations

Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer

Andreas Katopodis, Richard G. Warner, Rudolf O. Duthaler et al. · Journal of Clinical Investigation · 2002 · 74 citations · Full text

, , +17

Pharmacokinetic Investigation of a <sup>14</sup>C‐Labelled <i>β</i><sup>3</sup><i>/α</i> Tetrapeptide in Rats

Hansjörg Wiegand, B. Wirz, Alain Schweitzer et al. · Chemistry & Biodiversity · 2004 · 39 citations

Synthesis of and radioligand binding studies with a tritiated pinacidil analog: receptor interactions of structurally different classes of potassium channel openers and blockers

Paul W. Manley, Ulrich Quast, Hendrik Andres et al. · Journal of Medicinal Chemistry · 1993 · 37 citations

Rows per page

1–5 of 18